Insider · CIK 0001244823

BREITMEYER JAMES B

Reports to the SEC for 6 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001244823

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-16	VXRTVaxart, Inc.A Award	Director	AAward	+8,315 sh	—	—	87,115
2026-07-16	VXRTVaxart, Inc. · Stock Options (right to buy)A Award	Director	AAward	+16.6K sh	—	—	16,610
2026-04-23	VXRTVaxart, Inc.A Award	Director	AAward	+78.8K sh	—	—	78,800
2026-04-23	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director	AAward	+157K sh	—	—	157,400
2024-02-14	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+28.4K sh	—	—	28,400
2024-02-14	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+6,200 sh	—	—	6,200
2024-01-03	Oncternal Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,485 sh	$0.50	−$2,225.009	15,426
2024-01-03	Oncternal Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−51K sh	$0.50	−$25.3K	443,034
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+750K sh	—	—	750,000
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−637K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−100K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+2,000 sh	—	—	2,000
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+165K sh	—	—	165,000
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−66.9K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+22K sh	—	—	12,240
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+66.9K sh	—	—	66,890
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+637K sh	—	—	637,000
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+124K sh	—	—	123,750
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−7,000 sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−2,000 sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−124K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−750K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+7,000 sh	—	—	7,000
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−12.5K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−650K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−22K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−65K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+65K sh	—	—	65,000
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+12.5K sh	—	—	12,500
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−165K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+650K sh	—	—	650,000
2023-07-03	Oncternal Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−48K sh	$0.36	−$17.3K	493,989
2023-07-03	Oncternal Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,007 sh	$0.36	−$1,442.52	19,911
2023-04-14	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+47.8K sh	$0.30	+$14.3K	194,294
2023-04-14	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,250 sh	$0.29	+$652.5	196,544
2023-04-13	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+100K sh	$0.29	+$29K	146,544
2023-02-21	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+650K sh	—	—	650,000
2023-02-21	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+42.2K sh	—	—	42,196
2023-02-21	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+65K sh	—	—	65,000
2023-01-03	Oncternal Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,325 sh	$1.02	−$1,351.5	23,918
2023-01-03	Oncternal Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−27.8K sh	$1.02	−$28.3K	541,981
2022-07-28	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+12.5K sh	—	—	12,500
2022-07-28	Oncternal Therapeutics, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+124K sh	—	—	123,750
2022-07-28	Oncternal Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+18.8K sh	—	—	25,243
2022-07-28	Oncternal Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+186K sh	—	—	569,774
2022-06-21	OTONOMY, INC.Stock Option (right to buy)A Award	Director	AAward	+27.5K sh	—	—	27,500
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0

Recent filings

Accepted (ET)
Jul 174
BREITMEYER JAMES B0001437749-26-023810
SEC(opens sec.gov)
May 14
BREITMEYER JAMES B0001437749-26-014528
SEC(opens sec.gov)
Feb 154
BREITMEYER JAMES B0001209191-24-003413
SEC(opens sec.gov)
Jan 54
BREITMEYER JAMES B0001209191-24-000970
SEC(opens sec.gov)
Oct 44
BREITMEYER JAMES B0001209191-23-052019
SEC(opens sec.gov)

Companies

Address

C/O VAXART, INC. 310 UTAH AVENUE, SUITE 150

SOUTH SAN FRANCISCO, CA, 94080